Page last updated: 2024-08-23

etoposide and imatinib mesylate

etoposide has been researched along with imatinib mesylate in 55 studies

Research

Studies (55)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	28 (50.91)	29.6817
2010's	24 (43.64)	24.3611
2020's	3 (5.45)	2.80

Authors

Authors	Studies
Barbusca, E; Cannizzo, G; Cascioferro, S; Daidone, G; Maggio, B; Mancuso, S; Plescia, F; Raffa, D; Raimondi, MV; Tolomeo, M	1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Joel, SP; Liu, WM; Stimson, LA	1
Nokihara, H; Ohe, Y	1
Adams, R; Albritton, K; Coffin, C; Goldsby, R; Pulsipher, M; Wagner, L	1
Andersson, PO; Brune, M; Gustavsson, B; Stockelberg, D; Wadenvik, H; Wernstedt, P	1
Smit, EF	1
Bishop, WR; Nakajima, A; Ohyashiki, K; Sumi, M; Tauchi, T	1
Gillenwater, HH; Wolf, T	1
Chuman, H	1
de Cremoux, P; Decaudin, D; Fréneaux, P; Judde, JG; Livartowski, A; Nemati, F; Pouillart, P; Poupon, MF; Sastre, X; Tran-Perennou, C	1
Battistel, C; Hartung, R; Kübler, HR; Lehmer, A; Paul, R; Treiber, U; van Randenborgh, H; Wagenpfeil, S; Wutzler, S	1
Lin, C; Liu, ZR; Yang, L	1
Bernardini, K; Buratti, T; Lanthaler, AJ; Mitterer, M	1
Fang, BJ; Song, YP; Wei, XD; Zheng, S	1
Akutsu, M; Furukawa, Y; Izumi, T; Kano, Y; Kobayashi, H; Mano, H; Tsunoda, S	1
Chen, H; Han, W; Huang, XJ; Liu, DH; Liu, KY; Xu, LP	1
Balleisen, L; Buss, EC; Emmerich, B; Fischer, T; Fruehauf, S; Hehlmann, R; Ho, AD; Hochhaus, A; Müller, MC; Ottmann, OG; Schuld, P; Topaly, J	1
Fioretos, T; Gullberg, U; Lassen, C; Olofsson, T; Richter, J; Svensson, E; Vidovic, K	1
Heath, J; Kanwar, VS; Krasner, CN; Pearce, JM	1
Bordier, V; de Cremoux, P; Decaudin, D; Ekue, R; Garcia, M; Grandjean, I; Lokiec, F; Poupon, MF; Rezaï, K; Weill, S	1
Ates, H; Pehlivan, M; Sercan, HO; Sercan, Z; Simsek, O	1
Alanoğlu, G; Coşkun, HS; Göksu, SS; Sahin, M	1
Alvarnas, JC; Blume, KG; Cherry, AM; Forman, SJ; Laport, GG; Negrin, RS; Palmer, JM; Slovak, ML; Snyder, DS; Wong, RM	1
Cornelissen, JJ; Schnog, JB; Van Hest, RM; Van't Veer, MB	1
de Lima, MC; Moreira, JN; Santos, A; Sarmento-Ribeiro, AB; Simões, S	1
Cordier, JF; Cottin, V; Girard, N; Lapalus, MG; Tronc, F	1
Li, Y; Mi, Y; Qiu, L; Wang, J; Zhao, Y; Zou, D	1
Ângelo, S; Moreira, JN; Pinto, AC; Simões, S	1
Crowley, LC; Elzinga, BM; McKenna, SL; O'Sullivan, GC	1
Belinka, BA; Gupta, A; Kachlany, SC; Le, A	1
Acar, H; Aydemir, E; Bayrak, OF; Gulluoglu, S; Ozen, M; Sahin, F; Sevli, S; Yalvac, ME	1
Baybay, H; Berrady, R; Bono, W; El Hatimi, A; Gallouj, S; Khammar, Z; Lahlou, M; Lamchachti, L; Mernissi, FZ	1
Alaggio, R; Bisogno, G; Cecchetto, G; Cheng, L; d'Amore, ES; Dall'Igna, P; Martignoni, G; Sperlì, D	1
Abella, E; Amigo, ML; Barrios, M; Bravo, P; Brunet, S; García, O; González-Campos, J; Hernández-Rivas, JM; Montesinos, P; Ribera, JM	1
Mackenzie, IC; Navsaria, H; Storey, A; Wray, H	1
Kravchenko, SK; Moiseyeva, TN; Sharkunov, NN; Vinogradova, OY; Zybunova, EE	1
Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A	1
Kurosu, T; Miura, O; Nagao, T; Oshikawa, G; Wu, N	1
Bond, HM; Buffa, P; Consoli, ML; Di Raimondo, F; Manzella, L; Massimino, M; Mesuraca, M; Morrone, G; Pennisi, MS; Romano, C; Sciacca, L; Stagno, F; Stella, S; Tirrò, E; Vigneri, P	1
Brezovšek, P; Eleršek, T; Filipič, M	1
Bae, SH; Chi, HS; Eom, HS; Hyun, MS; Jang, DY; Joo, YD; Jung, CW; Kim, DY; Kim, H; Kim, HJ; Kim, I; Kim, MK; Lee, GW; Lee, JH; Lee, KH; Lee, SM; Lee, WS; Lim, SN; Moon, JH; Park, S; Ryoo, HM; Shin, HJ; Sohn, SK; Won, JH; Yang, DH; Yun, SC	1
Barceló, D; Brezovsek, P; de Alda, ML; Elersek, T; Filipič, M; Heath, E; Korošec, M; Milavec, S; Negreira, N; Ščančar, J; Zonja, B	1
Bláha, L; Isidori, M; Piscitelli, C; Russo, C; Smutná, M	1
Blazejczyk, A; Dziegiel, P; Dzimira, S; Hildebrand, W; Krupa, A; Kutkowska, J; Obminska-Mrukowicz, B; Pawlak, A; Rapak, A; Strzadala, L; Wietrzyk, J; Ziolo, E	1
Chen, YH; Cheng, L; Jin, XB; Liao, FF; Lin, XH; Liu, MY; Wang, WZ; Wu, QQ; Zhu, JY	1
Domijan, AM; Gajski, G; Garaj-Vrhovac, V; Gerić, M	1
Isidori, M; Kundi, M; Lavorgna, M; Parrella, A; Russo, C	1
Boichuk, S; Dunaev, P; Galembikova, A; Mustafin, I; Valeeva, E	1
Filipic, M; Isidori, M; Knasmueller, S; Kundi, M; Mišík, M; Nersesyan, A	1
Fan, Z; Li, Z; Liang, A; Tian, X; Yang, M; Yu, W; Zhang, W; Zhou, J	1
Bin, T; Chen, S; Chen, X; Cheng, J; Liao, Y; OUYang, J; Zou, W	1
Chen, XJ; Liu, MY; Wang, WZ; Wu, QQ	1
Cao, Y; Chen, G; Jiang, X; Li, S; Zhang, L; Zhou, X	1

Reviews

5 review(s) available for etoposide and imatinib mesylate

Article	Year
[Recent progress in the treatment of ED small cell lung cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 5 Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Camptothecin; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Imatinib Mesylate; Irinotecan; Lung Neoplasms; Piperazines; Pyrimidines; Vincristine	2002
Treatment options for small cell lung cancer. Current oncology reports, 2004, Volume: 6, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Camptothecin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Imatinib Mesylate; Irinotecan; Lung Neoplasms; Male; Neoplasm Staging; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiotherapy, Adjuvant; Risk Factors; Sex Distribution; Smoking; Survival Rate; Treatment Outcome; United States	2004
[Current strategy of chemotherapy for reflactory bone and soft tissue sarcomas]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Carboplatin; Cisplatin; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Piperazines; Prognosis; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Taxoids	2004
In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy. International journal of cancer, 2005, Feb-20, Volume: 113, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Carcinoma, Small Cell; Cell Proliferation; Etoposide; Humans; Ifosfamide; Imatinib Mesylate; Immunoenzyme Techniques; Lung Neoplasms; Mice; Mice, Nude; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Topotecan; Transplantation, Heterologous	2005
Malignant perivascular epithelioid cell tumor in children: description of a case and review of the literature. Journal of pediatric surgery, 2012, Volume: 47, Issue:6 Topics: Abdominal Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biopsy; Child, Preschool; Combined Modality Therapy; Diagnostic Errors; Etoposide; Female; Humans; Imatinib Mesylate; Intestinal Obstruction; Ligaments; Liver Neoplasms; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Perivascular Epithelioid Cell Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Radiography; Sarcoma, Clear Cell; Sirolimus; X Chromosome Inactivation	2012

Trials

4 trial(s) available for etoposide and imatinib mesylate

Article	Year
Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation. Haematologica, 2007, Volume: 92, Issue:3 Topics: Adolescent; Adult; Antineoplastic Agents; Benzamides; Child; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Haplotypes; Histocompatibility; HLA Antigens; Humans; Imatinib Mesylate; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia; Lymphocyte Transfusion; Male; Methotrexate; Mitoxantrone; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Piperazines; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Tissue Donors; Treatment Outcome	2007
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis. Cancer, 2007, Apr-15, Volume: 109, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Cytarabine; Etoposide; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mitoxantrone; Piperazines; Pyrimidines; Survival Analysis; Treatment Outcome	2007
Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation. British journal of haematology, 2012, Volume: 159, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Imatinib Mesylate; Male; Mercaptopurine; Methotrexate; Middle Aged; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Vincristine; Young Adult	2012
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. American journal of hematology, 2015, Volume: 90, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Induction Chemotherapy; Male; Methotrexate; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Survival Analysis; Transplantation, Homologous; Vincristine	2015

Other Studies

46 other study(ies) available for etoposide and imatinib mesylate

Article	Year
Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-one. European journal of medicinal chemistry, 2008, Volume: 43, Issue:11 Topics: Apoptosis; Azepines; G1 Phase; HL-60 Cells; Humans; K562 Cells; Molecular Structure; Pyrazoles; Resting Phase, Cell Cycle	2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR-ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents. British journal of cancer, 2002, May-06, Volume: 86, Issue:9 Topics: Antineoplastic Agents; Benzamides; Cell Death; Cytarabine; Enzyme Inhibitors; Etoposide; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Immunoblotting; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Tumor Cells, Cultured	2002
Unexpected pleural effusions in 3 pediatric patients treated with STI-571. Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:8 Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow Transplantation; Camptothecin; Child; Combined Modality Therapy; Edema; Enzyme Inhibitors; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Irinotecan; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Lung Neoplasms; Male; Neoplasm Proteins; Neuroectodermal Tumors, Primitive; Piperazines; Pleural Effusion; Proto-Oncogene Proteins c-kit; Pyrimidines; Remission Induction; Sarcoma, Ewing; Testis; Topotecan	2002
Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia. Bone marrow transplantation, 2002, Volume: 30, Issue:12 Topics: Adult; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Betamethasone; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Humans; Imatinib Mesylate; Immunosuppressive Agents; Mitoxantrone; Neoplasm, Residual; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Homologous; Vincristine	2002
[New data presented at ASCO 2002 concerning small cell bronchial cancer]. Revue de pneumologie clinique, 2002, Volume: 58, Issue:5 Pt 2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carboplatin; Carcinoma, Small Cell; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Imatinib Mesylate; Lung Neoplasms; Piperazines; Prognosis; Pyrimidines; Quinolones; Smoking; Smoking Prevention; Survival Analysis; Treatment Outcome	2002
Efficacy of SCH66336, a farnesyl transferase inhibitor, in conjunction with imatinib against BCR-ABL-positive cells. Molecular cancer therapeutics, 2003, Volume: 2, Issue:3 Topics: Alkyl and Aryl Transferases; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Division; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Farnesyltranstransferase; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Interleukin-3; Leukemia, Myeloid, Acute; Piperazines; Piperidines; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Transfection; Treatment Outcome; Tumor Cells, Cultured	2003
In vitro cytotoxic effects of imatinib in combination with anticancer drugs in human prostate cancer cell lines. The Prostate, 2005, Jun-01, Volume: 63, Issue:4 Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Cyclophosphamide; Docetaxel; Drug Synergism; Estramustine; Etoposide; Humans; Imatinib Mesylate; Immunohistochemistry; In Vitro Techniques; Male; Piperazines; Prostatic Neoplasms; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Taxoids	2005
Phosphorylations of DEAD box p68 RNA helicase are associated with cancer development and cell proliferation. Molecular cancer research : MCR, 2005, Volume: 3, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Blotting, Western; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Etoposide; HeLa Cells; Humans; Imatinib Mesylate; K562 Cells; Neoplasms; Paclitaxel; Phosphorus Radioisotopes; Phosphorylation; Piperazines; Precipitin Tests; Pyrimidines; RNA Helicases; RNA Interference; Stilbenes; Tumor Necrosis Factor-alpha	2005
Monolateral renal infarction and erythromelalgia in a case of chronic myelogenous leukemia. American journal of hematology, 2006, Volume: 81, Issue:3 Topics: Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Erythromelalgia; Etoposide; Female; Humans; Hydroxyurea; Imatinib Mesylate; Infarction; Interferon-alpha; Kidney; Kidney Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Radiography	2006
[Study on the mechanisms of imatinib-resistance of cancer stem-like cells in K562/Vp16 cell line]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2005, Volume: 26, Issue:11 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Drug Resistance, Neoplasm; Etoposide; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Stem Cells; Piperazines; Pyrimidines	2005
Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines. Investigational new drugs, 2007, Volume: 25, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Benzamides; Camptothecin; Carboplatin; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Cytarabine; Depsipeptides; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Imatinib Mesylate; Irinotecan; K562 Cells; Leukemia; Lymphoma; Mercaptopurine; Piperazines; Pyrimidines; Time Factors	2007
Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells. Leukemia, 2007, Volume: 21, Issue:12 Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cells, Cultured; Chromones; Drug Resistance, Neoplasm; Etoposide; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Genes, Wilms Tumor; Hematopoietic Stem Cells; Humans; Imatinib Mesylate; Inositol; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Morpholines; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Recombinant Fusion Proteins; RNA, Neoplasm; Signal Transduction; Transduction, Genetic; WT1 Proteins	2007
Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy. Pediatric blood & cancer, 2008, Volume: 50, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Carcinoma, Small Cell; Celecoxib; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Imatinib Mesylate; Lymph Nodes; Lymphatic Metastasis; Ovarian Neoplasms; Piperazines; Pyrazoles; Pyrimidines; Sulfonamides; Thalidomide; Vinblastine	2008
Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide. BMC pharmacology, 2007, Oct-27, Volume: 7 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Drug Synergism; Etoposide; Female; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Mice; Mice, Nude; Piperazines; Pyrimidines; Transplantation, Heterologous	2007
Induction of apoptosis increases expression of non-canonical WNT genes in myeloid leukemia cell lines. Oncology reports, 2007, Volume: 18, Issue:6 Topics: Antineoplastic Agents; Benzamides; Caspase 3; Cell Line, Tumor; Cyclin D1; Etoposide; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Piperazines; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Wnt Proteins	2007
Bleomycin, etoposide and cisplatin (BEP) combination with concurrent imatinib mesylate (GLEEVEC) in chronic myeloid leukemia (CML) patient with mesenchymal tumor. Medical oncology (Northwood, London, England), 2008, Volume: 25, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cisplatin; Etoposide; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mesenchymoma; Piperazines; Pyrimidines	2008
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen. Blood, 2008, Aug-01, Volume: 112, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Child; Child, Preschool; Combined Modality Therapy; Dose Fractionation, Radiation; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Risk Factors; Siblings; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation	2008
Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib. American journal of hematology, 2008, Volume: 83, Issue:9 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cytarabine; Drug Interactions; Edema; Etoposide; Female; Humans; Imatinib Mesylate; Leucovorin; Methotrexate; Middle Aged; Piperazines; Pleural Effusion, Malignant; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sodium Potassium Chloride Symporter Inhibitors; Translocation, Genetic	2008
Simultaneous evaluation of viability and Bcl-2 in small-cell lung cancer. Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2008, Volume: 73A, Issue:12 Topics: Annexin A5; Antineoplastic Agents; Benzamides; Cell Survival; Enzyme Inhibitors; Etoposide; Flow Cytometry; Humans; Imatinib Mesylate; Lung Neoplasms; Piperazines; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Small Cell Lung Carcinoma	2008
Synchronous small-cell lung cancer and gastrointestinal stromal tumor: a case report. Presse medicale (Paris, France : 1983), 2009, Volume: 38, Issue:1 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Doxorubicin; Etoposide; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Palliative Care; Piperazines; Pyrimidines; Small Cell Lung Carcinoma; Stomach Neoplasms	2009
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy. Annals of hematology, 2009, Volume: 88, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pyrimidines; Salvage Therapy; Vincristine; Vindesine; Young Adult	2009
Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapy. Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:2 Topics: Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Etoposide; Humans; Imatinib Mesylate; Inhibitory Concentration 50; Male; Mitoxantrone; Neoplasm Metastasis; Piperazines; Prostatic Neoplasms; Pyrimidines; Vinblastine	2011
Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment. American journal of hematology, 2011, Volume: 86, Issue:1 Topics: Animals; Autophagy; Benzamides; Cell Line, Tumor; DNA Damage; Doxorubicin; Etoposide; Fusion Proteins, bcr-abl; Gene Knockdown Techniques; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Molecular Targeted Therapy; Piperazines; Pyrimidines; RNA, Small Interfering; Transfection	2011
In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells. Leukemia research, 2011, Volume: 35, Issue:11 Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Busulfan; Cell Line, Tumor; Daunorubicin; Drug Interactions; Drug Synergism; Etoposide; Exotoxins; Flow Cytometry; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia; Leukocytes; Lymphocyte Function-Associated Antigen-1; Membrane Potential, Mitochondrial; Mitoxantrone; Piperazines; Pyrimidines; Tumor Cells, Cultured	2011
The effects of chemotherapeutic agents on differentiated chordoma cells. Journal of neurosurgery. Spine, 2011, Volume: 15, Issue:6 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Lineage; Chordoma; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Imatinib Mesylate; Methotrexate; Piperazines; Pyrimidines; Vidarabine; Vincristine	2011
[Acquired ichthyosis and haematological malignancies: five cases]. Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:1 Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematologic Neoplasms; Hodgkin Disease; Humans; Ichthyosis; Imatinib Mesylate; Leukemia, Myeloid, Accelerated Phase; Lung Neoplasms; Lymphoma, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Parotid Neoplasms; Piperazines; Platelet Aggregation Inhibitors; Prednisone; Procarbazine; Pyrimidines; Retrospective Studies; Rituximab; Schizophrenia; Stomach Neoplasms; Vincristine	2012
α6 Integrin and CD44 enrich for a primary keratinocyte population that displays resistance to UV-induced apoptosis. PloS one, 2012, Volume: 7, Issue:10 Topics: Androstadienes; Antineoplastic Agents; Apoptosis; Benzamides; Camptothecin; Cell Proliferation; Cells, Cultured; Cisplatin; Drug Resistance; Etoposide; Fluorescent Antibody Technique; Gene Expression; Humans; Hyaluronan Receptors; Imatinib Mesylate; Integrin alpha6; Keratinocytes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Primary Cell Culture; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Tumor Suppressor Proteins; Ultraviolet Rays; Wortmannin	2012
[Successful treatment for Hodgkin's lymphoma in a female patient with Ph+ chronic myeloid leukemia]. Terapevticheskii arkhiv, 2012, Volume: 84, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Prednisone; Procarbazine; Pyrimidines; Remission Induction; Treatment Outcome; Vincristine	2012
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma. Journal of the National Cancer Institute, 2013, Aug-07, Volume: 105, Issue:15 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Dasatinib; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Staging; Piperazines; Platelet Transfusion; Prednisone; Primary Prevention; Procarbazine; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Survival Analysis; Thiazoles; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine; Vindesine	2013
Inhibition of the PI3K/Akt/GSK3 pathway downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2/M arrest and prominently enhances induction of apoptosis. PloS one, 2013, Volume: 8, Issue:11 Topics: Animals; Apoptosis; Benzamides; Cell Cycle; Cell Line; Etoposide; Flow Cytometry; fms-Like Tyrosine Kinase 3; Fusion Proteins, bcr-abl; Glycogen Synthase Kinase 3; Imatinib Mesylate; Immunoblotting; Immunoprecipitation; Janus Kinase 2; Mice; Nocodazole; Phosphatidylinositol 3-Kinases; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines	2013
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation. Carcinogenesis, 2014, Volume: 35, Issue:5 Topics: Benzamides; Catalysis; Cell Line, Tumor; Cell Proliferation; Etoposide; Extracellular Signal-Regulated MAP Kinases; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Interferon Regulatory Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phosphorylation; Piperazines; Protein Binding; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; Signal Transduction; Transcriptional Activation; Tumor Stem Cell Assay	2014
Toxicities of four anti-neoplastic drugs and their binary mixtures tested on the green alga Pseudokirchneriella subcapitata and the cyanobacterium Synechococcus leopoliensis. Water research, 2014, Apr-01, Volume: 52 Topics: Antineoplastic Agents; Benzamides; Chlorophyta; Cisplatin; Complex Mixtures; Drug Synergism; Ecotoxicology; Etoposide; Fluorouracil; Imatinib Mesylate; Piperazines; Pyrimidines; Synechococcus; Water Pollutants, Chemical	2014
Toxicity of the mixture of selected antineoplastic drugs against aquatic primary producers. Environmental science and pollution research international, 2016, Volume: 23, Issue:15 Topics: Antineoplastic Agents; Chlorophyta; Etoposide; Fluorouracil; Imatinib Mesylate; Phytoplankton; Synechococcus; Water Pollutants, Chemical	2016
Teratogenic effects of five anticancer drugs on Xenopus laevis embryos. Ecotoxicology and environmental safety, 2016, Volume: 133 Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Biological Assay; Capecitabine; Cisplatin; Embryo, Nonmammalian; Embryonic Development; Etoposide; Fluorouracil; Imatinib Mesylate; Teratogens; Toxicity Tests; Xenopus laevis	2016
A novel canine B-cell leukaemia cell line. Establishment, characterisation and sensitivity to chemotherapeutics. Veterinary and comparative oncology, 2017, Volume: 15, Issue:4 Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; Celecoxib; Cell Line, Tumor; Dexamethasone; Dog Diseases; Dogs; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Imatinib Mesylate; Leukemia, B-Cell; Mice; Neoplasm Transplantation; Piroxicam	2017
Selective and effective targeting of chronic myeloid leukemia stem cells by topoisomerase II inhibitor etoposide in combination with imatinib mesylate in vitro. Cell biology international, 2017, Volume: 41, Issue:1 Topics: Antigens, CD34; Apoptosis; Cell Line, Tumor; Cell Survival; Etoposide; Gene Expression Regulation, Leukemic; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Stem Cells; Signal Transduction; Topoisomerase II Inhibitors; Tumor Stem Cell Assay	2017
Combined cyto/genotoxic activity of a selected antineoplastic drug mixture in human circulating blood cells. Chemosphere, 2016, Volume: 165 Topics: Antineoplastic Agents; Cell Survival; Cells, Cultured; DNA Damage; Drug Interactions; Etoposide; Fluorouracil; Humans; Imatinib Mesylate; Lymphocytes; Male; Oxidative Stress; Reactive Oxygen Species	2016
Benzalkonium Chloride and Anticancer Drugs in Binary Mixtures: Reproductive Toxicity and Genotoxicity in the Freshwater Crustacean Ceriodaphnia dubia. Archives of environmental contamination and toxicology, 2018, Volume: 74, Issue:4 Topics: Animals; Antineoplastic Agents; Benzalkonium Compounds; Cisplatin; Cladocera; Comet Assay; Complex Mixtures; DNA Damage; Ecotoxicology; Etoposide; Female; Fluorouracil; Fresh Water; Imatinib Mesylate; Male; Reproduction; Toxicity Tests; Water Pollutants, Chemical	2018
Inhibition of fibroblast growth factor receptor-signaling sensitizes imatinib-resistant gastrointestinal stromal tumors to low doses of topoisomerase II inhibitors. Anti-cancer drugs, 2018, Volume: 29, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Phenylurea Compounds; Pyrimidines; Rad51 Recombinase; Receptors, Fibroblast Growth Factor; Signal Transduction; Topoisomerase II Inhibitors	2018
Environmental risk assessment of widely used anticancer drugs (5-fluorouracil, cisplatin, etoposide, imatinib mesylate). Water research, 2019, Nov-01, Volume: 164 Topics: Animals; Antineoplastic Agents; Cisplatin; Ecosystem; Etoposide; Fluorouracil; Humans; Imatinib Mesylate; Risk Assessment; Water Pollutants, Chemical	2019
Targeting RAD51 enhances chemosensitivity of adult T‑cell leukemia‑lymphoma cells by reducing DNA double‑strand break repair. Oncology reports, 2019, Volume: 42, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; DNA Breaks, Double-Stranded; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Knockdown Techniques; HEK293 Cells; Humans; Imatinib Mesylate; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Rad51 Recombinase; Recombinational DNA Repair; RNA, Small Interfering	2019
Secondary chronic myeloid leukemia following acute myeloid leukemia treated with autologous hematopoietic stem cell transplantation: a case report. Current medical research and opinion, 2020, Volume: 36, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Pyrimidines; Remission Induction; Transplantation, Autologous	2020
[Effect of Etoposide on Elimination of Chronic Myeloid Leukemia Stem Cells by Imatinib in Vivo]. Zhongguo shi yan xue ye xue za zhi, 2021, Volume: 29, Issue:2 Topics: Animals; Drug Resistance, Neoplasm; Etoposide; Fusion Proteins, bcr-abl; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Stem Cells	2021
Long-stranded non-coding RNA HCG11 regulates glioma cell proliferation, apoptosis and drug resistance via the sponge MicroRNA-144COX-2 axis. Cellular and molecular biology (Noisy-le-Grand, France), 2022, Feb-27, Volume: 67, Issue:6 Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Glioma; Humans; Imatinib Mesylate; MicroRNAs; RNA, Long Noncoding	2022